Cargando…
Acteoside and ursolic acid synergistically protects H(2)O(2)-induced neurotrosis by regulation of AKT/mTOR signalling: from network pharmacology to experimental validation
CONTEXT: Ursolic acid (UA) and acteoside (ATS) are important active components that have been used to treat Alzheimer’s disease (AD) because of their neuroprotective effects, but the exact mechanism is still unclear. OBJECTIVE: Network pharmacology was used to explore the mechanism of UA + ATS in tr...
Autores principales: | Qu, Yan-Jie, Ding, Min-Rui, Gu, Chao, Zhang, Li-Min, Zhen, Rong-Rong, Chen, Jin-Fang, Hu, Bing, An, Hong-Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487927/ https://www.ncbi.nlm.nih.gov/pubmed/36102631 http://dx.doi.org/10.1080/13880209.2022.2098344 |
Ejemplares similares
-
The pharmacokinetic property and pharmacological activity of acteoside: A review
por: Xiao, Yaosheng, et al.
Publicado: (2022) -
Acteoside attenuates hydrogen peroxide-induced injury of retinal ganglion cells via the CASC2/miR-155/mTOR axis
por: Xi, Xiaoting, et al.
Publicado: (2022) -
Synergistic Effects of Combination Therapy with AKT and mTOR Inhibitors on Bladder Cancer Cells
por: Kim, Hyera, et al.
Publicado: (2020) -
Ursolic Acid Attenuates High Glucose-Mediated Mesangial Cell Injury by Inhibiting the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin (PI3K/Akt/mTOR) Signaling Pathway
por: Wang, Er-Min, et al.
Publicado: (2018) -
Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells
por: Grabinski, Nicole, et al.
Publicado: (2012)